Home/Oncoinvent/Anders Månsson
AM

Anders Månsson

Chief Executive Officer

Oncoinvent

Oncoinvent Pipeline

DrugIndicationPhase
RadspherinPeritoneal metastasis from ovarian cancerPhase 2b
OI-1 AntibodyPTK7-targeting (various cancers)Pre-clinical